Study Summary
This trial is testing a new intervention to help people with substance use disorder by targeting brain biomarkers that make relapse more likely.
Eligible Conditions
- Stimulant Abuse
- Alcoholism
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 months
2 months
Percent of participants with clean drug screens
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Active tDCS
1 of 2
Sham tDCS
1 of 2
Experimental Treatment
Non-Treatment Group
80 Total Participants · 2 Treatment Groups
Primary Treatment: tDCS · Has Placebo Group · N/A
Active tDCSExperimental Group · 2 Interventions: Cognitive Training, tDCS · Intervention Types: Behavioral, Device
Sham tDCS
Behavioral
PlaceboComparator Group · 1 Intervention: Cognitive Training · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
2008
Completed Phase 3
~4100
tDCS
2017
Completed Phase 2
~730
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,259 Previous Clinical Trials
1,484,981 Total Patients Enrolled
9 Trials studying Alcoholism
2,105 Patients Enrolled for Alcoholism
Kelvin Lim, MDPrincipal InvestigatorUniversity of Minnesota
2 Previous Clinical Trials
134 Total Patients Enrolled
Eligibility Criteria
Age 18 - 65 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You meet the MINI 7 diagnostic criteria for either stimulant use disorder (SUD) or alcohol use disorder (AUD).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments